Nutrients and pharmacological management of Metabolic syndrome

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDepartment of pharmacology and pharmacotherapyhu_HU
dc.contributor.authorGhim, Nayoung
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentMegyeri, Attila
dc.contributor.opponentdeptKenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2022-08-29T09:18:42Z
dc.date.available2022-08-29T09:18:42Z
dc.date.created2021-07-06
dc.description.abstractMetabolic syndrome is a public health problem defined by a cluster of interconnected components that increase the risk of cardiovascular atherosclerotic diseases and T2DM. Metabolic syndrome has a pleiotropic pathophysiology related to increasing body fat and distribution and insulin resistance. Recently approved anti-obesity drugs can be prescribed to reduce body weight, particularly abdominal visceral fat. Anti-diabetics such as metformin, lipid-lowering medications, RAAS blockers, and calcium channels exert many metabolic effects including anti-inflammation. Treatment is best achieved with a combination of lifestyle modifications and therapeutic agents that can help reduce insulin resistance, and others that target specific components of metabolic syndrome.hu_HU
dc.description.correctorhbk
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent35hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/336860
dc.language.isoenhu_HU
dc.subjectMetabolic syndromehu_HU
dc.subjectDiabeteshu_HU
dc.subjectInsulin resistancehu_HU
dc.subjectObesityhu_HU
dc.subjectAntidiabeticshu_HU
dc.subject.dspaceAntidiabeticshu_HU
dc.subject.dspaceTreatment of Dyslipidemiahu_HU
dc.subject.dspaceAnti-Obesity Drugshu_HU
dc.subject.dspaceAntihypertensiveshu_HU
dc.subject.dspaceCOVID and Metabolic Syndromehu_HU
dc.subject.dspaceIntermittent fastinghu_HU
dc.subject.dspaceVery low carbohydrate ketogenic diethu_HU
dc.titleNutrients and pharmacological management of Metabolic syndromehu_HU
Fájlok